tirzepatide patent challenge Top drug expirations in next 5 years Semaglutide & Tirzepatide Patent Considerations

Washington, D.C., American: National Academies Press (US) Copyright 2000 by the National Academy of Sciences

Why patients prefer no-additive formulations: Providers like ProRx have responded to this demand by specifically offering no-additive tirzepatide options, making this a key differentiator in the telehealth GLP-1 marketplace

While women experienced less heart attacks than men, the underlying causes were often misdiagnosed highlighting a need for more awareness and advocacy around these conditions

Your provider will help determine the best administration method based on your preferences and comfort level. ContinuEM Urgent Care does not currently accept insurance for weight loss injections. To provide you with the fastest patient care, please call to schedule your In-Person Appointment, Virtual Visit, or COVID-19 Appointment